Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001709.5(BDNF):c.508G>A(p.Val170Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000041 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
BDNF (HGNC:1033): (brain derived neurotrophic factor) This gene encodes a member of the nerve growth factor family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. Binding of this protein to its cognate receptor promotes neuronal survival in the adult brain. Expression of this gene is reduced in Alzheimer's, Parkinson's, and Huntington's disease patients. This gene may play a role in the regulation of the stress response and in the biology of mood disorders. [provided by RefSeq, Nov 2015]
The BDNF c.754G>A variant is predicted to result in the amino acid substitution p.Val252Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);.;Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);.;Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);Loss of methylation at K169 (P = 0.0778);.;